Transdermal vaccine effective in treating Alzheimer's disease in mouse model
Published 13 November 2007
There has been tremendous interest about developing a vaccine to treat Alzheimer’s disease.
'Although side effects have been a problem in initial human vaccine studies, this new study is potentially very exciting. The prospect of a practical and non-invasive vaccine delivered through this new method is particularly welcome. However, more research and evaluation is now needed to investigate whether it is a safe and effective method to deliver the vaccine in humans.'
Clive Ballard
Director of research
Alzheimer's Society